Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration
-
TIER IV's AI Pilot system certified for Level 4 autonomous bus service in Nagano Prefecture
-
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
-
MNC Statement on AGA and Election
-
Camping World Announces Pricing of Offering of Class A Common Stock
-
CalciMedica Announces Pricing of Public Offering of Common Stock
-
South Australian Painting Services Expands Reach with New Location in Mount Barker
-
Only Green Lights Up Crypto with Permanent Green Candles
-
M.D.C. HOLDINGS ANNOUNCES DEPARTURE OF FOUNDER AND EXECUTIVE CHAIRMAN LARRY A. MIZEL AND PRESIDENT AND CHIEF EXECUTIVE OFFICER DAVID D. MANDARICH AT THE END OF 2024
-
Laird Superfood and Smirk's LTD, Two Colorado Companies, Renew Strategic Partnership
-
Silver Star Properties REIT provides important update to shareholders regarding, among others, Maryland and Harris County Litigations, timelines for completing financial filings, and resumption of Dis
-
Brane X Named to TIME’s List of the Best Inventions of 2024
-
Westlake Chemical Partners LP Announces Third Quarter 2024 Distribution
-
Change of Director’s Interest Notice
-
TCW Names David Kim as Head of Japan
-
OpenSSL Forms Business Advisory Committees: Shape the Future - Join Now!
-
Hyundai Motor Reveals Bold and Efficient Hydrogen FCEV Concept Previewing New Design Language
-
A bond forged through the fragrance
-
Thomas Jefferson University Announces Tender Pricing Information
-
UnitedAg Set to Celebrate 45th Sapphire Anniversary at 2025 INSPIRE Conference
-
Infinity Bancorp Announces Quarterly Cash Dividend
-
Skychain Comments on Dissident Confusion
-
CareTrust REIT, Inc. Announces Pricing of Upsized Public Offering of Common Stock
-
Resource Capital Fund VI L.P. Ceases to be an Insider of Talon Metals Corp.
-
CNOOC Limited Announces Mero3 Project Commences Production
-
Renesas Reports Financial Results for the Third Quarter Ended September 30, 2024
-
Comtech Announces Leadership Updates
-
Athabasca Oil Announces 2024 Third Quarter Results Highlighted by Strong Free Cash Flow and Continued Execution on Share Buybacks
-
BRICS Summit safeguards the stability of greater BRICS collaboration
-
KWESST Micro Systems Inc. Announces Pricing of Public Offering
-
Every second this past year 3 girls and 2 boys experienced child sexual violence
-
Just Flow Events & Marketing Grows Team with the Addition of Three New Staff Members
-
WM Announces Pricing of $5.2 Billion Senior Notes
-
Toshiba Starts Sample Shipments of Gate Driver IC for Three-Phase Brushless DC Motors in Diverse Automotive Applications
-
Avery Dennison Prices €500 Million Senior Notes Offering
-
Renesas Announces Consolidated Forecasts
-
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrol
-
InvestBev Commits $50 Million to Fuel Growth in the Distillery and Bourbon Barrel Sector
-
MOIN Successfully Complete POC for Cross-Border Tuition Payments, Paving the Way for Solution Commercialization
-
Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura
-
Renesas Announces Key Leadership Changes to Continue Strategic Growth
-
The Fresh Market Opens New Lincoln Park Store Welcoming Community to an Elevated Food Experience
-
Enovix Announces Pricing of Public Offering of Common Stock
-
The Fresh Market Opens New Crofton Location Providing Guests An Exceptional Shopping Experience
-
Sound Financial Bancorp, Inc. Q3 2024 Results
-
NEXE Innovations Announces Financial Results for the Three Months Ended August 31, 2024
-
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
-
Newfoundland Discovery Announces Share Consolidation
-
EISAI PRESENTS LATEST CLINICAL FINDINGS SUGGESTING INHIBITION OF TAU PROPAGATION BY ANTI-MTBR TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE (CTAD)
-
Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

